Evidence map›Paper›PMID 27014871›Full record

ArticlePloS one2016

Phosphoproteome Analysis of Invasion and Metastasis-Related Factors in Pancreatic Cancer Cells.

Xiaodong Tan, Peng Liu, Yinpeng Huang, Lei Zhou, Yifan Yang, Huaitao Wang, Boqiang Yu, Xiangli Meng, Xiaobo Zhang, Feng Gao

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xiaodong TanDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
Peng LiuDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
Yinpeng HuangDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
Lei ZhouDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
Yifan YangDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
Huaitao WangDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
Boqiang YuDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
Xiangli MengDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
Xiaobo ZhangDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
Feng GaoDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, P.R.China.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanisms of abnormal protein phosphorylation that regulate cell invasion and metastasis in pancreatic cancer remain obscure. In this study, we used high-throughput phosphorylation array to test two pancreatic cancer cell lines (PC-1 cells with a low, and PC-1.0 cells with a high potential for invasion and metastasis). We noted that a total of 57 proteins revealed a differential expression (fold change ≥ 2.0). Six candidate proteins were further validated by western blot with results found to be accordance with the array. Of 57 proteins, 32 up-regulated proteins (e.g. CaMK1-α and P90RSK) were mainly involved in ErbB and neurotrophin signaling pathways as determined using DAVID software, while 25 down-regulated proteins (e.g. BID and BRCA1) were closely involved in apoptosis and p53 signaling pathways. Moreover, four proteins (AKT1, Chk2, p53 and P70S6K) with different phosphorylation sites were found, not only among up-regulated, but also among down-regulated proteins. Importantly, specific phosphorylation sites can affect cell biological functions. CentiScaPe software calculated topological characteristics of each node in the protein-protein interaction (PPI) network: we found that AKT1 owns the maximum node degrees and betweenness in the up-regulation protein PPI network (26 nodes, average path length: 1.89, node degrees: 6.62±4.18, betweenness: 22.23±35.72), and p53 in the down-regulation protein PPI network (17 nodes, average path length: 2.04, node degrees: 3.65±2.47, betweenness: 16.59±29.58). In conclusion, the identification of abnormal protein phosphorylation related to invasion and metastasis may allow us to identify new biomarkers in an effort to develop novel therapeutic drug targets for pancreatic cancer treatment.

Indexed as

ApoptosisCell Line, TumorGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessNeoplasm MetastasisNeoplasm ProteinsPancreatic NeoplasmsPhosphorylationProtein Interaction MapsProteomeSignal TransductionNeoplasm ProteinsProteome

Identifiers

PMID27014871
PMCPMC4807880
OpenAlexW2311995289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.